The indirect fluorescent antibody (FA) method is widely used for the detection of antibodies to Legionella pneumophila in the diagnosis of Legionnaires' disease (LD). Initially diagnosis was uncomplicated by serological variants of the causative organism but since 1979 a total of six serogroups has been described.' The multiplicity of serological types of the organism is important in laboratory diagnosis and some workers have, rightly, been concerned in case infections caused by serovariants are overlooked through the use of only the serogroup 1 antigen. 2 During 1980 a total of 1792 serum specimens from 1431 patients were submitted to the Division of Microbiological Reagents & Quality Control from clinical diagnostic laboratories for estimation of antibody titres to L pneumophila. This study reports the results obtained on testing these specimens against six monovalent antigens representing each of the serogroups and assesses the adequacy of the present policy of this division in supplying a serogroup 1 antigen to diagnostic laboratories and limiting the issue of additional serogroup antigens to reference laboratories.
Material and methods

SERA
Results on all sera from patients with respiratory Accepted for publication 3 After drying the slides were examined by epiillumination using a Zeiss microscope equipped with x 10 eyepiece, x 63 water immersion objective, HB 050 mercury vapour lamp, and interference Table 2 .
HEALTHY BLOOD DONORS Antibody titres of the blood donors against the six antigens are shown in Table 3 . Of these 15 (3 %) showed titres of > 1/16 against the serogroup 1 antigen. However a total of 83 (16 5%) showed such titres with at least one of the six antigens.
Diagnosis of Legionella pneumophila infections by means offormolised yolk sac antigen In the current series of patients three possible cases of non-serogroup 1 infections would have been unrecognised had only the serogroup 1 antigen been used. These patients showed fourfold rises in antibody titre to the serogroup 4 antigen, but were negative against the serogroup 1 antigen. However, in one case the histological changes observed after death were those of "shock lung" and there was no evidence of pneumonia to support the diagnosis of LD. Thus out of a total of 37 LD cases two were apparently non-serogroup 1 infections and would not have been diagnosed using the serogroup 1 antigen. We are now evaluating the use of a polyvalent FYSA comprising serogroups 2-6 as an additional screening antigen to detect the rare non-serogroup 1 infections, although some such infections would in any event be indicated using the serogroup 1 antigen by virtue of the broad serological reactivity of human sera against the six serogroup antigens. 10 At the present time the testing of sera from patients showing negative results or non-diagnostic titres against the serogroup 1 antigen but considered on clinical grounds probably to be LD can be performed in reference laboratories against all available antigens. The truism that special attention will be proficienc given to quality control specimens is better tha self evident but is it not entirely for the These fac reasons advanced by the authors that assessmer laboratories will wish to appear to be adjunct r efficient. For Oxford-1 11287
